Regulatory & Legal

A major multi-vendor study confirms AI's power for precision HER2 scoring, promising to improve diagnostics and accelerate personalized cancer therapies.

Quanterix has submitted a multi-biomarker blood test to the FDA, a move that could revolutionize early Alzheimer's diagnosis and patient care.

A bipartisan bill in Congress aims to give veterans access to emerging mental health treatments, including the novel, non-hallucinogenic compound MEAI.

A new FDA-approved device offers a drug-free alternative for severe rheumatoid arthritis. Rush University is the first in Chicago to implant the system.

A new report reveals AI-powered disinformation is bypassing firewalls, costing billions. Experts say firms are dangerously unprepared for this new reality.

Eli Lilly partners with China's Zonsen PepLib, betting on its novel peptide platforms to fuel the next wave of therapies in oncology and metabolism.

A new partnership aims to slash waste and streamline clinical trials, heralding a tech-driven transformation in the backbone of drug development.

The rehab therapy software giant capped a pivotal year with key AI partnerships, a new executive team, and a major push into remote care, signaling its next era.

An independent analysis shows a specialized OB/GYN staffing model improves maternal outcomes, lowers C-section rates, and delivers a significant return on investment.

Colonial Heights schools adopt AI gun detection to boost safety, but the tech faces scrutiny over its real-world effectiveness and privacy implications.

With 144% customer growth, Maestra's all-in-one AI platform is luring brands from established players, sparking a tech stack consolidation debate.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.

At a critical juncture, Abcourt Mines brings a long-time consultant in-house, betting his expertise can overcome financial hurdles and unlock project value.

A new report reveals a major shift in hospital spending, with tech and infrastructure costs now rising faster than drugs for the first time in a decade.

Osisko Development hires a regulatory powerhouse, signaling a strategic push to de-risk its path to gold production amid rising environmental scrutiny.

With a $201M war chest, Muzero Acquisition Corp joins a revitalized SPAC market, targeting the next big tech-enabled company in a high-stakes search.

The resolution of a high-stakes patent lawsuit sees Cirrus Logic license pSemi's power tech, signaling a major shift in the semiconductor IP landscape.

TeraWulf is acquiring old industrial sites in KY and MD, adding massive power capacity for the AI boom while aiming to stabilize regional energy grids.

A major investment from Ares and DaVita will help Elara Caring expand in-home care, launching a new model for chronic kidney disease patients.

After a brutal cold snap, Michiganders face huge energy bills. Consumers Energy is offering aid, but it highlights a growing crisis of affordability.